patient populations that respond differently to treatment and have different outcomes. 7 Another challenge in interpreting the trial evidence for this group of patients is the subjectivity associated with assigning a PS to any given patient. A recent
Search Results
Management of Patients With Lung Cancer and Poor Performance Status
Ajeet Gajra, Alissa S. Marr, and Apar Kishor Ganti
New Treatment Guidelines for Penile Cancer
Philippe E. Spiess
NCCN Panel on bladder and penile cancers. With the use of non–evidence-based treatment approaches, outcomes can widely vary. To clarify some of the controversies associated with the treatment of penile cancer, NCCN has created inaugural NCCN Clinical
Improving Health Equity and Reducing Disparities in Pediatric and Adolescent/Young Adult Oncology: In Support of Clinical Practice Guidelines
Justine M. Kahn and Melissa Beauchemin
, adolescents, and young adults (AYA; aged 15–39 years) with HL exceed 95%, with event-free survival (EFS) rates >85%. 4 The treatment successes in HL are attributed, in part, to 4 key factors: (1) research to identify disease-related predictors of poor outcome
Infusion-Compatible Antibiotic Formulations for Rapid Administration to Improve Outcomes in Cancer Outpatients With Severe Sepsis and Septic Shock: The Sepsis STAT Pack
Jason D. Goldman, Amelia Gallaher, Rupali Jain, Zach Stednick, Manoj Menon, Michael J. Boeckh, Paul S. Pottinger, Stephen M. Schwartz, and Corey Casper
measure relative risk of (1) cumulative 30-day mortality, (2) development of SSh, or (3) the combined outcome of cumulative 30-day mortality or development of SSh. Multivariate models were constructed to control for prespecified confounding variables
Feasibility and Effectiveness of Self-Management Education and Coaching on Patient Activation for Managing Cancer Treatment Toxicities
Doris Howell, Gregory R. Pond, Denise Bryant-Lukosius, Melanie Powis, Patrick T. McGowan, Tutsirai Makuwaza, Vishal Kukreti, Sara Rask, Saidah Hack, and Monika K. Krzyzanowska
also examined preliminary estimates of effectiveness based on patient-reported outcomes. Methods Participants and Recruitment Procedures Ethics approval was obtained from the Ontario Cancer Research Ethics Board for all participating sites
Identification and Characterization of Avoidable Hospital Admissions in Patients With Lung Cancer
Eric M. Lander, Xuanyi Li, Li-Ching Huang, Amanda S. Cass, Wade T. Iams, Emily A. Skotte, Jennifer G. Whisenant, Robert A. Ramirez, Sally J. York, Travis J. Osterman, Jennifer A. Lewis, Christine M. Lovly, Yu Shyr, and Leora Horn
associated with better outcomes or within patients’ goals of care. Hospital stays in patients with cancer are generally 1.5 days longer and carry a 2-fold higher risk of in-hospital mortality compared with inpatient admissions for other conditions. 6 Most
HSR19-084: Real-World Treatment Patterns and Clinical Outcomes in Non-Small Cell Lung Cancer Patients with EGFR Exon 20 Insertion Mutations
Maral DerSarkissian, Shuanglian Li, Aaron Galaznik, Rachel Bhak, Iryna Bocharova, Thomas Kulalert, Huamao M. Lin, Hui Huang, and Mei Sheng Duh
experience of NSCLC patients with EGFR exon 20 insertion mutations are limited. This study describes patient characteristics, treatment patterns, and survival outcomes of NSCLC patients with EGFR exon 20 insertions based on real world data. Methods
Wealth, Health Expenditure, and Cancer: A National Perspective
Jad Chahoud, Adele Semaan, and Alyssa Rieber
Background The health care system in the United States is characterized by an unsustainable increase in spending with penultimate outcomes. 1 , 2 In 2013, the United States spent a total of $2.9 trillion on health, which is approximately $9
Advances in the Care of Adult Patients With Acute Lymphoblastic Leukemia: Optimism Tempered by Reality
Joseph C. Alvarnas and Patrick A. Brown
Outcomes for patients with acute lymphoblastic leukemia (ALL) have improved dramatically over the past 4 decades. Overall 5-year relative survival rates for patients with ALL have increased from 40.6% during the period between 1975 and 1977 to 70
Outpatient Management of Pulmonary Embolism in Cancer: Data on a Prospective Cohort of 138 Consecutive Patients
Carme Font, Alberto Carmona-Bayonas, Aranzazu Fernández-Martinez, Carmen Beato, Andrés Vargas, Pere Gascon, and Remedios Otero
spectrum of PE may vary from sudden life-threatening events to unsuspected radiologic findings on scheduled CT scans. 2 , 3 In several series of patients with acute symptomatic PE, cancer has been identified as a predictor for adverse outcomes. 4 , 5
